Abstract
Bradykinin is a nonapeptide that is generated in plasma and tissues in response to injury and infection. Once released, bradykinin exhibits physiological effects suggesting it is a mediator of the pain and inflame-mation associated with a variety of pathological conditions. Physiological effects include the stimulation and sensitization of nociceptive afferent neurons, vasodilation, increased vascular permeability and enhanced fluid secretion from epithelia. These actions are mediated by specific membrane receptors for bradykinin that exist in many tissues, including the nervous system, smooth muscle, epithelia and fibroblasts. Recently, a series of bradykinin analogues was described (Vavrek and Stewart, 1985) which includes specific, competitive antagonists of bradykinin-induced contraction of guinea pig ileum and rat uterus in vitro and of bradykinin-induced hypotension in vivo. These compounds hold great promise as novel analgesic/ anti-inflammatory agents and permit, for the first time, assessment of the physiological and pathophysiological roles of bradykinin. In the present report we describe results of studies of the effects of the antagonists on bradykinin receptor binding, receptor-coupled transduction systems, isolated smooth muscle, and in vivo animal models of pain and hyperalgesia. The results suggest that pharmacologically distinct types of bradykinin receptors may exist in different tissues.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Armstrong, D., 1970, Pain, in: “Handbook of Experimental Pharmacology,” Vol. 25 (Supplement), 434–481, E.G. Erdos, ed., Springer-Verlag, BerlinHeidleberg, New York.
Boschcov, P., Paiva, A.C.M., Paiva, T.B., and Shimuta, S.I., 1984, Further evidence for the existence of two receptor sites for bradykinin responsible for the diphasic effect in the rat isolated duodenum, Br. J. Pharmac., 83:591–600.
Burch, R.M., and Axelrod, J., 1987, Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: Evidence for G protein regulation of phospholipase A2, Proc. Natl. Acad. Sci., USA, in press.
Carey, F., Haworth, D., and Whalley, E.T., 1986, Pro-inflammatory effects of cyclic kinin analogues, Brit. J. Pharmacol., 89:806P.
Carretero, 0.A., Miyazaki, S., and Scicli, A.G., 1981, Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor captopril, Hypertension 3: 18–22.
Christiansen, S.C., Proud, D., and Cochrane, C.G., 1987, Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects, J. Clin. Invest., 79:188–197.
Clark, M.A., Bomalaski, J.S., Conway, T.M., Wartell, J., Sand Crooke, S.T., 1986, Differential effect of aspirin and dexamethasone on phospholipase A2 and C activities and arachidonic acid release from endothelial cells in response to bradykinin and leukotriene D4, Prostaglandins 32: 703–708.
Clark, W.G., 1979, Kinins and the peripheral and central nervous systems, in: “Handbook of Experimental Pharmacology,” Vol. 25 (Supplement), 312–356, E.G. Erdos, ed., Springer-Verlag, Berlin-Heidleberg-New York.
Claesson, H.E., Lindgren, J.A., and Hammarstrom, J., 1977, Prostaglandin E2 production in 3T3 cells transformed by polyoma virus raises the intracellular adenosine 3’:5’-monophosphate levels, Eur. J. Biochem., 74:13–18.
Cleason, G., Fareed, J., Larsson, C., Kindel, G., Arielly, S., Simonsson, R., Messmore, H., and Balis, J.U., 1979, Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptides, Adv. Exp. Med. Biol., 120b:691–713.
Collier, H.O.J., Dinneen, L.C., Johnson, C.A., and Schneider, C., 1968, The abdominal constriction response and its suppression by analgesic drugs in the mouse, Br. J. Pharmacol., 32:295–310.
Collier, H.O., and Lee, I.R., 1963, Nociceptive responses of guinea pigs to intradermal injections of bradykinin and kallidin-10, Brit. J. Pharmacol., 21:151.
Conklin, B., Burch, R.M., Steranka, L.R., and Axelrod, J., 1987, Distinct bradykinin receptors mediate stimulation of prostaglandin synthesis by endothelial cells and fibroblasts. J. Neurosci., in press.
Couture, R., Gaudreau, P., St-Pierre, S., and Regoli, D., 1980, The dog common carotid artery: A sensitive bioassay for studying vasodilator effects of substance P and kinins, Can. J. Physiol. Pharmacol., 58:1234.
Deffenue, G., Pegrassi, L., and Lumachi, B., 1966, The use of bradykinininduced effects in rats as an assay for analgesic drugs, J. Pharm. Pharmacol., 18:135.
Douglas, W.D., 1985, Polypeptides-angiotensin, plasma kinins, and others, in: “The Pharmacological Basis of Therapeutics,” A.G. Gilman, L.S. Goodman, T.W. Rall, and F. Murad, eds., Toronto-London: Macmillan, New York.
Fox, R.J., Goldsmith, R., Kidd, J.J., and Lewis, G.P., 1961, Bradykinin as a vasodilator in man, J. Physiol., London, 157:589–602.
Franz, M., and Mense, S., 1975, Muscle receptors with group IV afferent responding to application of bradykinin, Brain Research 92: 369–383.
Gaudreau, P., Barabe, J., St-Pierre, S., and Regoli, D., 1981, Pharmacological studies of kinins in venous smooth muscles, Can. J. Physiol. Pharmacol., 59:371.
Gavras, H., Benetos, A., and Gavras, I., 1987, Contribution of bradykinin to maintenance of normal blood pressure, Hypertension (Suppl III ), 9: 147–149.
Greaves, M., and Shuster, S., 1967, Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamine, J. Physiol. 193:255–267.
Haddy, F.J., Emerson, T.E. Jr., Scott, J.B., and Daugherty, R.M. Jr., 1970, The effect of kinins on the cardiovascular system, in: “Handbook of Experimental Pharmacology,” Vol. 25, 362.384, E.G. Erdos, ed., Springer-Verlag, Berlin-Heidleberg, New York.
Hamberg, U., Vahtera, E., and MoilaRen, L., 1978, Functionally active alpha2-macroglobulin and kinin release in synovial fluids of rheumatoid arthritis, Agents and Actions 8: 50.
Hirsch, E.F., Nakajima, T., Oshima, G., Erdos, E.G., and Herman, C.M., 1974, Kinin system responses in sepsis after trauma in man, J. Surg. Res., 17: 147–153.
Hong, S.L., and Deykin, D., 1982, Activation of phospholipases A2 and C in pig aortic endothelial cells synthesizing prostacyclin, J. Biol. Chem., 257:7151–7154.
Jansi, M.K., Katori, M., and Lewis, G.P., 1969, Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases, Ann. Rheum. Dis., 28:497.
Jezdinsky, J., and Halek, J., 1974, The effects of some analgesics and neuroleptics upon the reflexive and affective components of the formaldehyde-and bradykinin-induced nociceptive reactions in rats, Activ. Nerv. Sup. (Praha), 16:226–228.
Kaplan, A.P., 1987, Kinins and bone resorption in rheumatic disease, Arth. Rheum., 30:589–592.
Khan, A.A., Raja, S.N., Campbell, J.N., Hartke, T.V., and Meyer, R.A., Bradykinin sensitizes nociceptors to heat stimuli, Neurosci. Abstr. 12:218.
Lawrence, I.D., Lichtenstein, L.M., Kagey-Sobotka, A., Vavrek, R.J., Stewart, J.M., and Proud, D., 1987, Induction of histamine release from human skin mast cells by bradykinin antagonists, Fed. Proc., 46:1126.
Lim, R.K.S., 1968, Neuropharmacology of pain and analgesia, in: “Proc. III Int. Pharmacol. Meet.,” Vol. 9, 424–437, Pharmacology of pain, R.K.S. Lim, D. Armstrong, and E.G. Pardo, eds., Pergamon, Oxford.
Manning, D.C., Vavrek, R., Stewart, J.M., and Snyder, J.H., 1986, Two bradykinin binding sites with picomolar affinities, J. Pharmacol. Exp. Ther., 237:504–512.
Marceau, F., Lussier, A., Regoli, D., and Giroud, J.P., 1983, Pharmacology of kinins: Their relevance to tissue injury and inflammation, Gen. Pharmac., 14:209–229.
Mason, D.T., and Melmon, K.L., 1965, Effects of bradykinin on forearm venous tone and vascular resistance in man, Circulat. Res., 17:106–113.
McGiff, J.C., Itskovitz, H.D., Terragno, N.A., and Wong, P.Y.K., 1976, Modulation and mediation of the action of the renal dallikrein-kinin system by prostaglandins, Fed. Proc., 35:175–180.
McPherson, G.A., 1985, Analysis of radioligand binding experiments, J. Pharmacol. Meth., 14:213–228.
Melmon, K.L., Webster, M.E., Goldfinger, S.E., and Seegmiller, J.E., 1967, The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies, Arthr. and Rheum., 10: 13.
Meyer, R.A., and Campbell, J.N., 1981, Myelinated nociceptive afferents account for the hyperalgesia that follows a burn to the hand, Science 213: 1527–1529.
Miller, D.H., and Margolius, H.S., 1987, Kallikrein-kininogen systems, in: “Endocrinology,” L.J. DeGroot, G.F. Cahill, W.D. O’Dell, L. Martini, J.T. Potts, D.H. Nilson, E. Steinberger, and A.I. Winegrad, eds., Gune Stratton, New York.
Mizrahi, J., Dion, S., D’Orleans-Juste, P., Escher, E., Drapeau, G., and Regoli, D., 1985, Tachykinin receptors in smooth muscles: A study with agonists (substance P, neurokinin A) and antagonists, Eur. J. Pharmacol., 118:25.
Murad, F., Mittal, C., Arnold, W.P., Ichihara, K., Braughler, M., and El-Zayat, M., 1978, Properties and regulation of guanylate cyclase, in: “Molecular Biology and Pharmacology of Cyclic Nucleotides,” G. Falco, and R. Paoletti, eds., Elsevier, pp. 33–42.
Murayama, T., and Ui, M., 1976, Receptor-mediated inhibition of adenylate cyclase and stimulation of arachidonic acid release in 3T3 fibroblasts, J. Biol. Chem., 260:7226–7233.
Nies, A.S., Forsyth, R.P., Williams, H.E., and Melmon, K.L., 1968, Contribution of kinins to endotoxin shock in unanesthetized rhesus monkeys, Circ. Res., 22:155–164.
Portilla, D., and Morrison, A.R., 1986, Bradykinin-induced changes in inositol trisphosphate mass in MDCK cells, Biochem. Biophys. Res. Comm., 140:644–649.
Proud, D., Togias, A., Nacleria, R.M., Crush, S.A., Norman, P.S., and Lichtenstein, L.M., 1983, Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen, J. Clin. Invest., 72:1678–1685.
Randall, L.O., and Selitto, J.J., 1957, A method for measurement of analgesic activity on inflamed tissues, Arch. Int. Pharmacodyn., 113:233.
Regoli, D., and Barabe, J., 1980, Pharmacology of kinins, Pharmacol. Rev., 32:1–46.
Robinson, J.A., Klodnycky, Loeb, H.S., Racic, M.R., and Gunnar, R.M., 1975, Endotoxin, prekallikrein, complement and systemic vascular resistance, Am. J. Med., 59: 61–67.
Rozengurt, E., and Collins, M., 1983, Molecular aspects of growth factor action: Receptors and intracellular signals, J. Pathol., 141:309–331.
Sharma, J.N., Zeithlin, I.J., Deodhar, S.D., and Buchanan, W.W., 1983, Detection of kallikrein-like activity in inflamed synovial tissue, Arch. Int. Pharmacodyn., 262:279–286.
Snider, R.M., and Richelson, E., 1984, Bradykinin receptor-mediated cyclic GMP formation in a nerve cell population (murine neuroblastoma clone N1E-115), J. Neurochem., 43:1749–1754.
Szolcsanyi, J., 1987, Selective responsiveness of polymodal nociceptors of the rabbit ear to capsaicin, bradykinin and ultra-violet irradiation, J. Physiol., 388:9–23.
Vavrek, R.J., and Stewart, J.M., 1985, Competitive antagonists of bradykinin, Peptides 6: 161–164.
Whalley, E.T., Nwator, I.A., Stewart, J.M., and Vavrek, R.J., 1987, Analysis of the receptors mediating vascular actions of bradykinin, NauynSchmeideberg’s Arch. Pharmacol., in press.
Yamashita, T., Tsuda, T., Hamamori, Y., and Takai, Y., 1986, Possible involvement of cAMP and calcium ion in prostaglandin E1-induced elevation of c-myc mRNA levels in Swiss 3T3 fibroblasts, J. Biol. Chem., 261:1687816882.
Zeitlin, I.J., and Smith, A.M., 1973, Mobilization of tissue kallikrein in inflammatory disease of the colon, Gut, 14: 133–138.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Steranka, L.R., Burch, R.M., Vavrek, R.J., Stewart, J.M., Enna, S.J. (1988). Multiple Bradykinin Receptors: Results of Studies Using a Novel Class of Receptor Antagonists. In: Kito, S., Segawa, T., Kuriyama, K., Tohyama, M., Olsen, R.W. (eds) Neuroreceptors and Signal Transduction. Advances in Experimental Medicine and Biology, vol 236. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5971-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5971-6_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5973-0
Online ISBN: 978-1-4757-5971-6
eBook Packages: Springer Book Archive